Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Nieto

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|January 10, 2002
Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograftY Nieto, S I Bearman, E J Shpall, et al.
Breast Cancer Research and Treatment|November 20, 1998
Weekly continuous infusion of 5-fluorouracil with oral leucovorin in metastatic breast cancer patients with primary resistance to doxorubicinY Nieto, M Martín, J L Alonso, et al.
Blood Cancer Journal|October 17, 2015
Romidepsin targets multiple survival signaling pathways in malignant T cellsB C Valdez, J E Brammer, Y Li, et al.
Oncology|June 10, 2008
Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanomaM González-Cao, S Viteri, A Díaz-Lagares, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantY Nieto, P J Cagnoni, E J Shpall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancerP J Cagnoni, Y Nieto, E J Shpall, et al.
Bone Marrow Transplantation|July 5, 2005
Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility studyJ A Gutman, S I Bearman, Y Nieto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantationY Nieto, P J Cagnoni, S Nawaz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|January 10, 2002
Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograftY Nieto, S I Bearman, E J Shpall, et al.
Breast Cancer Research and Treatment|November 20, 1998
Weekly continuous infusion of 5-fluorouracil with oral leucovorin in metastatic breast cancer patients with primary resistance to doxorubicinY Nieto, M Martín, J L Alonso, et al.
Blood Cancer Journal|October 17, 2015
Romidepsin targets multiple survival signaling pathways in malignant T cellsB C Valdez, J E Brammer, Y Li, et al.
Oncology|June 10, 2008
Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanomaM González-Cao, S Viteri, A Díaz-Lagares, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantY Nieto, P J Cagnoni, E J Shpall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancerP J Cagnoni, Y Nieto, E J Shpall, et al.
Bone Marrow Transplantation|July 5, 2005
Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility studyJ A Gutman, S I Bearman, Y Nieto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantationY Nieto, P J Cagnoni, S Nawaz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Pageof 6